Eli Lilly & Co. agreed to buy U.S. biopharma company Morphic Holding Inc. for about $3.2 billion to gain experimental therapies for inflammatory bowel disease and other chronic illnesses.
Remy Cointreau SA sales slumped in the first quarter of its fiscal year as the Cognac maker suffered from falling demand in the US and tougher markets in Southeast Asia.
L’Oreal SA is buying a 10% stake in Galderma Group AG, a Swiss maker of injectable skin fillers, with the two agreeing to collaborate on new products to reduce the signs of aging.
Five women say they were raped by former Harrods owner Mohamed Al Fayed when they worked at the London department store, while more than 20 claim they were sexually assaulted by the late billionaire, the BBC reported.
Honeywell International Inc. plans to spin off its advanced materials division, the latest move by the industrial conglomerate to reshape its portfolio and streamline its holdings.
Vivendi SE said investor CIAM has filed with the Paris Commercial Court to postpone its shareholder meeting scheduled for next month and delay its plan to break up the company.
Honeywell International Inc. is exploring a separation of its aerospace business as the industrial company faces calls from activist Elliott Investment Management for a breakup.
French power provider Engie SA increased its sales of clean energy last year, signing new contracts with companies including Meta Platforms Inc. in the US and German chemical maker BASF SE.